Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression
International Journal of Geriatric Psychiatry July 1, 2023 Benjamin Vanderschelden, M. A. Gebara, H. Oughli et al. 13 citations
Among older adults with treatment-resistant depression, intravenous ketamine treatment was associated with improvements in psychological well-being and sleep, but not in suicidality. The findings suggest that ketamine may enhance aspects of mental health beyond depressive symptoms in this population, though its effect on suicidal thoughts remains unclear.